These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11937333)

  • 1. Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability.
    Maruyama T; Asada M; Shiraishi T; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jun; 10(6):1743-59. PubMed ID: 11937333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a selective EP4-receptor agonist. Part 2: 3,7-dithiaPGE1 derivatives with high selectivity.
    Maruyama T; Asada M; Shiraishi T; Ishida A; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):989-1008. PubMed ID: 11836108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of a selective EP4-receptor agonist. Part 1: discovery of 3,7-dithiaPGE1 derivatives and identification of their omega chains.
    Maruyama T; Asada M; Shiraishi T; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):975-88. PubMed ID: 11836107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity.
    Maruyama T; Asada M; Shiraishi T; Ishida A; Egashira H; Yoshida H; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2029-31. PubMed ID: 11454473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability.
    Maruyama T; Asada M; Shiraishi T; Sakata K; Seki A; Yoshida H; Shinagawa Y; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2033-5. PubMed ID: 11454474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of an 8-aza-5-thiaProstaglandin E1 analog as a highly selective EP4 receptor agonist.
    Kambe T; Maruyama T; Naganawa A; Asada M; Seki A; Maruyama T; Nakai H; Toda M
    Chem Pharm Bull (Tokyo); 2011; 59(12):1494-508. PubMed ID: 22130372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-hydroxy-17,17-trimethylene 9beta-chloro PGF derivatives.
    Tani K; Naganawa A; Ishida A; Egashira H; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):1107-14. PubMed ID: 11836121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives.
    Tani K; Naganawa A; Ishida A; Sagawa K; Harada H; Ogawa M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
    Bioorg Med Chem; 2002 Apr; 10(4):1093-106. PubMed ID: 11836120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
    de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
    Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of γ-lactam analogs of PGE₂ as EP4 and EP2/EP4 agonists.
    Kambe T; Maruyama T; Nakai Y; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
    Bioorg Med Chem; 2012 Jun; 20(11):3502-22. PubMed ID: 22546206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of orally available 8-aza-5-thiaProstaglandin E1 analogs as highly selective EP4 agonists.
    Kambe T; Maruyama T; Nakano M; Yamaura Y; Shono T; Seki A; Sakata K; Maruyama T; Nakai H; Toda M
    Chem Pharm Bull (Tokyo); 2011; 59(12):1523-34. PubMed ID: 22130375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The C-terminal domain of the human EP4 receptor confers agonist-induced receptor desensitization in a receptor hybrid with the rat EP3beta receptor.
    Neuschäfer-Rube F; Hänecke K; Püschel GP
    FEBS Lett; 1997 Sep; 415(2):119-24. PubMed ID: 9350980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid.
    Neuschäfer-Rube F; Oppermann M; Möller U; Böer U; Püschel GP
    Mol Pharmacol; 1999 Aug; 56(2):419-28. PubMed ID: 10419563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical synthesis and biological evaluation of 9-halogenated PGF analogues.
    Tani K; Naganawa A; Ishida A; Egashira H; Odagaki Y; Miyazaki T; Hasegawa T; Kawanaka Y; Sagawa K; Harada H; Ogawa M; Maruyama T; Nakai H; Ohuchida S; Kondo K; Toda M
    Bioorg Med Chem; 2002 Jun; 10(6):1883-94. PubMed ID: 11937346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.
    Kambe T; Maruyama T; Nakai Y; Yoshida H; Oida H; Maruyama T; Abe N; Nishiura A; Nakai H; Toda M
    Bioorg Med Chem; 2012 Apr; 20(7):2235-51. PubMed ID: 22386979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous EP4 prostaglandin receptors coupled positively to adenylyl cyclase in Chinese hamster ovary cells: pharmacological characterization.
    Crider JY; Griffin BW; Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jan; 62(1):21-6. PubMed ID: 10765975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2.
    Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N
    J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329.
    Nitta M; Hirata I; Toshina K; Murano M; Maemura K; Hamamoto N; Sasaki S; Yamauchi H; Katsu K
    Scand J Immunol; 2002 Jul; 56(1):66-75. PubMed ID: 12100473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7,7-Difluoroprostacyclin derivative, AFP-07, a highly selective and potent agonist for the prostacyclin receptor.
    Chang CS; Negishi M; Nakano T; Morizawa Y; Matsumura Y; Ichikawa A
    Prostaglandins; 1997 Feb; 53(2):83-90. PubMed ID: 9112287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel EP2/EP4 dual agonist with high subtype-selectivity.
    Kambe T; Maruyama T; Nakano M; Nakai Y; Yoshida T; Matsunaga N; Oida H; Konaka A; Maruyama T; Nakai H; Toda M
    Bioorg Med Chem Lett; 2012 Jan; 22(1):396-401. PubMed ID: 22119471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.